Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-10.1%
5Y CAGR+17.1%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.1%/yr
Annual compound
5Y CAGR
+17.1%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.61M | -20.9% |
| 2024 | $86.74M | -11.5% |
| 2023 | $98.04M | +3.7% |
| 2022 | $94.54M | +73.8% |
| 2021 | $54.39M | +74.9% |
| 2020 | $31.10M | +34.3% |
| 2019 | $23.15M | - |